Pharmaceutical & Life Sciences News

Dr. Reddy’s Can’t Sell Generic Opioid Treatment, Judge Rules (2)

July 16, 2018, 12:48 PM

Indivior Plc persuaded a federal judge to block sales of Dr. Reddy’s Laboratories Ltd.’s copies of opioid treatment Suboxone film while a patent-infringement lawsuit is pending.

Dr. Reddy’s had received approval in June from the U.S. Food and Drug Administration to sell a generic version of Indivior’s market-leading treatment for opioid dependence, but was temporarily blocked from selling the medicine while the judge took a closer look at the legal dispute.

Indivior’s Suboxone.
Photographer: George Frey/Bloomberg

A Dr. Reddy’s representative said the company “strongly disagrees” with the findings of a federal judge in Newark, New Jersey, and plans to appeal. Officials at Indivior didn’t...

To read the full article log in. To learn more about a subscription click here.